Diffuse large B cell lymphoma historical perspective: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
No edit summary
Line 2: Line 2:
{{Diffuse large B cell lymphoma}}
{{Diffuse large B cell lymphoma}}


Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
In 1865, Samuel Wilks used the term "Hodgkin's disease" in Annals of medicine on the name of "Thomas Hodgkin" who published a paper on some morbid appearances of absorbent glands and spleen in 1832<ref>Wilks S. Cases with enlargement of the lymphatic glands and spleen (or Hodgkin’s disease) with remarks. Guy’s Hosp Rep. 1865;11:57–67</ref>. Consequently, the other heterogeneous lymph node neoplastic disorder was later named as Non-Hodgkin's Lymphoma (NHL). Non-Hodgkin lymphoma is now one of the leading malignancies worldwide and Diffuse Large b cell Lymphoma (DLBCL) is one of the most common types of Non-Hodgkin Lymphoma


==References==
==References==

Revision as of 02:09, 13 July 2018

Diffuse large B cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diffuse large B cell lymphoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diffuse large B cell lymphoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diffuse large B cell lymphoma historical perspective

CDC on Diffuse large B cell lymphoma historical perspective

Diffuse large B cell lymphoma historical perspective in the news

Blogs on Diffuse large B cell lymphoma historical perspective

Directions to Hospitals Treating Diffuse large B cell lymphoma

Risk calculators and risk factors for Diffuse large B cell lymphoma historical perspective

In 1865, Samuel Wilks used the term "Hodgkin's disease" in Annals of medicine on the name of "Thomas Hodgkin" who published a paper on some morbid appearances of absorbent glands and spleen in 1832[1]. Consequently, the other heterogeneous lymph node neoplastic disorder was later named as Non-Hodgkin's Lymphoma (NHL). Non-Hodgkin lymphoma is now one of the leading malignancies worldwide and Diffuse Large b cell Lymphoma (DLBCL) is one of the most common types of Non-Hodgkin Lymphoma

References

  1. Wilks S. Cases with enlargement of the lymphatic glands and spleen (or Hodgkin’s disease) with remarks. Guy’s Hosp Rep. 1865;11:57–67


Template:WikiDoc Sources